Most Recent
Developer’s challenge to NSW Ports decision an abuse of process, court told
Mayfield Development is barred from bringing claims already traversed in a competition case by the ACCC that was thrown out by a court, NSW Ports has told an appeals court.
High Court asked to hear coverage row over Knox Grammar abuse claims
The Uniting Church has asked the High Court to weigh in after an appeals court found insurer Allianz was not on the hook for claims of abuse at exclusive Sydney private school Knox Grammar.
Bayer can’t get High Court to hear Xarelto patent fight
The High Court won't hear Bayer's appeal of an invalidity finding over patents for blood thinner Xarelto, despite the company's claim the decision has "profound" consequences for drug R&D.
Full Court asked to turn lights back on in failed Queensland electricity class action
A failed competition class action by Queensland electricity customers accusing utility companies Stanwell and CS Energy of misusing their market power has been appealed to the Full Court.
4 ways the High Court could go on CFOs
As the High Court hears oral arguments this week on the reach of power to make common fund orders for firms and funders bringing class actions, Lawyerly gives a cheat sheet on what the justices could do.
Aldi won’t swallow finding it infringed copyright for Little Bellies puffs
Discount grocery giant Aldi has lodged an appeal after a court found its Mamia Baby Puffs copied the look of rival Little Bellies baby snacks.
Construction PRO
‘Unsound’: High Court arguments over historic St Kilda Rd property panned
The valuer general has knocked arguments by developer WSTI Properties in a High Court dispute over a heritage property in Melbourne, saying the contentions are "unavailable and unsound”. 
Construction PRO
VCAT should have considered Cremorne development’s impact on views, court told
EPC Pacific is facing a fight after it got the go-ahead from Yarra City Council to build an 11-storey mixed use office building in an inner city Melbourne suburb.
Otsuka appeals win for Sun Pharma over injectable Abilify patent
Otsuka Pharmaceuticals is challenging a decision revoking its patent for an injectable version of antipsychotic drug Abilify.
High Court asked to find India can’t dodge $111.3M arbitral award
The High Court has been asked to overturn a ruling that found India was immune from a suit seeking to enforce a $111.3 million arbitral award because it did not involve a 'commercial' matter.